F-group (family)
2002.1.1.41 A_deaminase
Ligands and drugs
410
Member domains
144
with ligand contacts (≤ 4 Å)
35.1% of members
77
with DrugDomain annotations
18.8% of members
58
with a DrugBank compound
14.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2002.1.1.41 belongs to X-group 2002 TIM beta/alpha-barrel, which binds 8.7 ligand superclasses per 20 proteins, broader than 71% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00552 | DCF | Pentostatin | 9 |
| DB00141 | NAG | N-Acetylglucosamine | 8 |
| DB03015 | PRH | 6-hydroxy-1,6-dihydro purine nucleoside | 7 |
| DB00173 | ADE | Adenine | 4 |
| DB02472 | HPR | 7,8-dihydroinosine | 3 |
| DB04076 | HPA | Hypoxanthine | 3 |
| DB04440 | PUR | Nebularine | 3 |
| DB02096 | FR2 | FR221647 | 2 |
| DB02219 | CXS | 3-(cyclohexylamino)propanesulfonic acid | 2 |
| DB02616 | FR0 | FR117016 | 2 |
| DB02796 | 9DI | 9-deazainosine | 2 |
| DB02830 | FR9 | FR236913 | 2 |
| DB03220 | FR6 | FR-234938 | 2 |
| DB03370 | FR7 | FR239087 | 2 |
| DB03572 | FR3 | FR230513 | 2 |
| DB04218 | 1DA | 1-Deaza-Adenosine | 2 |
| DB04566 | IMP | Inosinic Acid | 2 |
| DB07711 | EH9 | (2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol | 2 |
| DB07783 | FR4 | 1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE | 2 |
| DB07785 | FRC | 1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 107 |
| MGmetal | MAGNESIUM ION | 44 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 42 |
| DCF | 2'-DEOXYCOFORMYCIN | 8 |
| EIF | [(2~{R},3~{R},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-4-fluoranyl-4-methyl-3-oxidanyl-oxolan-2-yl]methyl dihydrogen phosphate | 8 |
| PRH | 6-HYDROXY-1,6-DIHYDRO PURINE NUCLEOSIDE | 6 |
| ADE | ADENINE | 4 |
| HPA | HYPOXANTHINE | 3 |
| 9DI | 9-DEAZAINOSINE | 2 |
| CAmetal | CALCIUM ION | 2 |
| CCN | ACETONITRILE | 2 |
| CL | CHLORIDE ION | 2 |
| COmetal | COBALT (II) ION | 2 |
| CXS | 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID | 2 |
| ES4 | 6-chloro-9H-purine | 2 |
| HPR | 6-HYDROXY-7,8-DIHYDRO PURINE NUCLEOSIDE | 2 |
| IMP | INOSINIC ACID | 2 |
| MCF | (8R)-3-(5-S-methyl-5-thio-beta-D-ribofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol | 2 |
| NAmetal | SODIUM ION | 2 |
| PUR | PURINE RIBOSIDE | 2 |